Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
UC San Francisco scientists identify 'Achilles heel' of drug-resistant cancers

UC San Francisco scientists identify 'Achilles heel' of drug-resistant cancers

Salk researchers solve genetic 'whodunnit' for cancer gene

Salk researchers solve genetic 'whodunnit' for cancer gene

New nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancer

New nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancer

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Aggressive local therapy for stage IV lung cancer patients improves progression-free survival

Aggressive local therapy for stage IV lung cancer patients improves progression-free survival

SBRT found to be safe treatment for patients with multiple metastases

SBRT found to be safe treatment for patients with multiple metastases

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC

Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Novel method uses just a drop of blood to monitor effect of lung cancer therapy

Novel method uses just a drop of blood to monitor effect of lung cancer therapy

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

Frequent surveillance imaging not associated with improved overall postoperative survival

Frequent surveillance imaging not associated with improved overall postoperative survival

Aggressive breast cancer hijacks normal protective physiological process to survive

Aggressive breast cancer hijacks normal protective physiological process to survive